New scan seeks to spot lung damage earlier

NCT ID NCT05914506

Summary

This study is testing whether a new type of MRI scan, using a special inhaled gas called hyperpolarized xenon, can better detect and monitor lung scarring (fibrosis) and related heart effects in people with progressive fibrosing lung disease. It aims to see if this scan is more sensitive than current tests at spotting early changes and tracking how the disease progresses or responds to treatment. The study involves 30 participants who are already prescribed anti-fibrotic drugs.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Aarhus University, Department of Clinical Medicine, MR Research Centre

    Aarhus, 8200, Denmark

Conditions

Explore the condition pages connected to this study.